drugset / Trial / NCT01811225

Smoking, Sex Hormones, and Pregnancy

NCT01811225

Phase 2 Completed 95 enrolled University of Minnesota
RandomizedCrossoverOpen-labelPrevention

Summary

The investigators aim to (1) examine the association between levels of progesterone (Prog), allopregnanolone (Allo), and the estradiol/progesterone (E2/P) ratios with smoking-related symptomatology during ad libitum smoking and (2) determine the association between Prog, Allo, and E2/P with the changes in smoking-related symptomatology and response to nicotine following overnight abstinence

Timeline

Start
2012-12
Primary completion
2017-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 200 mg

Indications